Publications by authors named "Gene Barbour"

Claim this Profile
C
Cathepsin D Drives the Formation of Hybrid Insulin Peptides Relevant to the Pathogenesis of Type 1 Diabetes.
Samantha A Crawford, Timothy A Wiles, Janet M Wenzlau, Roger L Powell, Gene Barbour

Diabetes· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin B-chain hybrid peptides are agonists for T cells reactive to insulin B:9-23 in autoimmune diabetes.
Janet M Wenzlau, James E DiLisio, Gene Barbour, Mylinh Dang, Anita C Hohenstein

Front Immunol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4 T Cells Reactive to Hybrid Insulin Peptides Are Indicators of Disease Activity in the NOD Mouse.
Rocky L Baker, Braxton L Jamison, Timothy A Wiles, Robin S Lindsay, Gene Barbour

Diabetes· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An insulin-IAPP hybrid peptide is an endogenous antigen for CD4 T cells in the non-obese diabetic mouse.
Timothy A Wiles, Thomas Delong, Rocky L Baker, Brenda Bradley, Gene Barbour

J Autoimmun· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion.
Thomas Delong, Timothy A Wiles, Rocky L Baker, Brenda Bradley, Gene Barbour

Science· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutting Edge: Nonobese Diabetic Mice Deficient in Chromogranin A Are Protected from Autoimmune Diabetes.
Rocky L Baker, Brenda Bradley, Timothy A Wiles, Robin S Lindsay, Gene Barbour

J Immunol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutting edge: CD4 T cells reactive to an islet amyloid polypeptide peptide accumulate in the pancreas and contribute to disease pathogenesis in nonobese diabetic mice.
Rocky L Baker, Thomas Delong, Gene Barbour, Brenda Bradley, Maki Nakayama

J Immunol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetogenic T-cell clones recognize an altered peptide of chromogranin A.
Thomas Delong, Rocky L Baker, Jing He, Gene Barbour, Brenda Bradley

Diabetes· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells.
Thomas Delong, Rocky L Baker, Nichole Reisdorph, Richard Reisdorph, Roger L Powell, Gene Barbour

Diabetes· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromogranin A is an autoantigen in type 1 diabetes.
Brian D Stadinski, Thomas Delong, Nichole Reisdorph, Richard Reisdorph, Roger L Powell, Gene Barbour

Nat Immunol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory T cells prevent transfer of type 1 diabetes in NOD mice only when their antigen is present in vivo.
Daniel R Tonkin, Jing He, Gene Barbour, Kathryn Haskins

J Immunol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoptive transfer of islet antigen-autoreactive T cell clones to transgenic NOD.Ea(d)mice induces diabetes indicating a lack of I-E mediated protection against activated effector T cells.
Samantha A Roberts, Gene Barbour, Marissa R Matarrese, David L Mason, Edward H Leiter

J Autoimmun· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis